Synchron

New York, NY · Founded 2016 · Privately Held (backing)

Developer of an implantable stent-rode designed to create a brain-computer interface. Synchron is based in New York, NY and was founded in 2016. It was valued at $385 million at its later-stage round in Dec 2022, the last priced event on record. It has raised $340 million across 1 recorded round; the latest was a $49.9 million early-stage round in Nov 2022.

PMV mark · valuation
$385.0M
Oct 2026
Priced at
its later-stage round
Dec 2022
Total raised
$339.9M
Last round
Early Stage VC
Nov 2022
How much has Synchron raised?
$339.9Macross 1 recorded rounds · Nov 2022 – Nov 2022

Most recently, Synchron raised $49.9M in its Early Stage VC (Nov 2022).

Free account
More of Synchron with a free account
  • ·The complete investor list: 47 names
  • ·Watch Synchron: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Synchron round by round

1 rounds
Nov 2022Early Stage VC$49.9MSEC filing▮
22 investors participated

How much has Synchron raised?

Synchron has raised $340 million in total; 1 of its rounds is on record. The largest on record was a $49.9 million early-stage round in Nov 2022.

Synchron has filed 1 Form D with the SEC, most recently in Dec 2022 ($49.9 million sold to 22 investors).

Synchron investors

47 investors are on record for Synchron, including Alumni Ventures, Khosla Ventures, United States Department of War and National Institutes of Health. By type, the record holds 12 venture capital firms and 1 family office. The early-stage round in Nov 2022 drew 22 investors.

For fundraisers
Raising for a company like Synchron?

47 investors have backed Synchron.

See all 47 investors →

Frequently asked about Synchron

How much has Synchron raised?
Synchron has raised $339.9M in total across 1 recorded funding rounds.
When was Synchron's last funding round?
Synchron's most recent recorded round was Early Stage VC in Nov 2022, raising $49.9M.